Biomedical Engineering Reference
In-Depth Information
3. Hurd S. The impact of COPD on lung health worldwide: epidemiology and
incidence. Chest 2000; 117:1S-4S.
4. Barnes PJ. Chronic obstructive pulmonary disease. New Engl J Med 2000;
343:269-280.
5. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease:
molecular and cellular mechanisms. Eur Respir J 2003; 22:672-688.
6. Barnes PJ, Hansel TT. New treatments for chronic obstructive pulmonary
disease. Lancet 2004; 1:217-222.
7. Barnes PJ. New concepts in COPD. Ann Rev Med 2003; 54:113-129.
8. Gross CP, Anderson GF, Powe NR. The relation between funding by the
National Institutes of Health and the burden of disease. N Engl J Med 1999;
340:1881-1887.
9. ERS. European Lung White Book. European Respiratory Society 2003; l-182.
10. Ramsey SD, Sullivan SD. The burden of illness and economic evaluation for
COPD. Eur Respir J Suppl 2003; 41:29s-35s.
11. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy
for the diagnosis, management, and prevention of chronic obstructive pulmon-
ary disease. NHLBI
=
WHO Global Initiative for Chronic Obstructive Lung
Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;
163:1256-1276.
12. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and struc-
tural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care
Med 2001; 163:1304-1309.
13. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G,
Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation
in patients with fixed airflow obstruction due to asthma or chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 2003; 167:418-424.
14. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE,
Maestrelli P, Ciaccia A, Fabbri LM. CD8
รพ
T-lymphocytes in peripheral
airways of smokers with chronic obstructive pulmonary disease. Am J Respir
Crit Care Med 1998; 157:822-826.
15. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp
CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is asso-
ciated with severity of airway inflammation in smokers. Am J Respir Crit Care
Med 1998; 158:1277-1285.
16. Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, Donner CF.
Inflammatory cells and mediators in bronchial lavage of patients with chronic
obstructive pulmonary disease. Eur Respir J 1998; 12:380-386.
17. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8
and tumor necrosis factor-a in induced sputum from patients with chronic
obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;
153:530-534.
18. Fabbri L, Beghe B, Caramori G, Papi A, Saetta M. Similarities and discrepan-
cies between exacerbations of asthma and chronic obstructive pulmonary
disease. Thorax 1998; 53:803-808.
19. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction
in chronic obstructive lung disease. N Engl J Med 1968; 278:1355-1360.
